Yes, 2.5 mg of Crestor (rosuvastatin) is effective at lowering LDL cholesterol. Clinical trials show it reduces LDL by roughly 42% on average, which is a substantial drop that places it in the moderate-intensity statin range. However, 2.5 mg is not an FDA-approved dose, and the context for using it matters.
How Much 2.5 mg Actually Lowers Cholesterol
Rosuvastatin is one of the most potent statins available, and even at very low doses it delivers significant LDL reduction. In dose-ranging studies, 2.5 mg lowered LDL cholesterol by an average of 42%, while the lowest marketed dose of 5 mg lowered it by about 45%. That 3-percentage-point gap is small because statin dose-response follows a predictable pattern: each time you double the dose, you gain only about 4.5% more LDL reduction. So halving the dose from 5 mg to 2.5 mg costs relatively little in terms of cholesterol-lowering power.
For comparison, the 1 mg dose reduced LDL by 34%, and the highest tested dose of 80 mg reduced it by 65%. The biggest jump in effectiveness happens at the lower end of the dosing range, with diminishing returns as the dose climbs.
Why 2.5 mg Isn’t an Official Dose
The FDA-approved dosing range for Crestor is 5 mg to 40 mg once daily, and the drug is only manufactured in 5 mg, 10 mg, 20 mg, and 40 mg tablets. There is no 2.5 mg pill. To take this dose, you would need to split a 5 mg tablet in half. This means 2.5 mg is technically off-label, though it’s a dose that clinicians prescribe in specific situations.
The fact that it’s off-label doesn’t mean it’s ineffective or unsafe. It simply means the manufacturer didn’t seek formal approval at that strength, likely because the difference between 2.5 mg and 5 mg is marginal enough that a separate tablet didn’t make commercial sense.
Who Typically Uses This Dose
People of Asian Descent
One of the most well-documented reasons for prescribing 2.5 mg is ancestry. Research shows that people of Asian descent absorb and retain significantly more rosuvastatin in their bloodstream compared to white patients taking the same dose. Chinese subjects had roughly 2.3 times higher drug exposure, Malay subjects about 1.9 times, and Asian-Indian subjects about 1.6 times higher. These differences appear to stem partly from how the liver clears the drug through bile, not just from genetic variations in transport proteins.
In practical terms, a 2.5 mg dose in a person of Chinese descent may produce blood levels similar to what a 5 mg dose produces in a white patient. This is why prescribing guidelines specifically note that lower starting doses should be considered for Asian patients.
People With Statin Side Effects
Muscle pain and soreness are the most common reason people stop taking statins. For those who’ve experienced these side effects on standard doses, a very low daily dose or even intermittent dosing (a few times per week) with rosuvastatin is a recognized strategy. Because rosuvastatin has a long half-life in the body, it remains active even with less frequent dosing. Some patients take 2.5 mg daily, others take 5 mg every other day or a few times per week, all with meaningful LDL reductions and fewer muscle complaints.
People With Modest Cholesterol Goals
Not everyone needs the maximum LDL reduction. If your cardiovascular risk is low to borderline (a 10-year risk in the 5% to 7.5% range, for instance), a 42% LDL drop from 2.5 mg may be more than enough to reach your target. Current cardiovascular guidelines emphasize matching statin intensity to risk level. Moderate- or high-intensity therapy is recommended for people with diabetes, very high LDL (190 mg/dL or above), or elevated 10-year risk. But for people at lower risk who still benefit from some cholesterol lowering, a lower dose can strike a reasonable balance.
How It Compares to Other Statins
The 42% LDL reduction from 2.5 mg of rosuvastatin is roughly equivalent to what you’d get from 20 mg of atorvastatin or 40 mg of simvastatin. This is what makes rosuvastatin unusual: even its sub-approved dose outperforms standard doses of older statins. If you’re someone who needs to take the smallest possible amount of medication, rosuvastatin at 2.5 mg gives you more cholesterol-lowering per milligram than any other option.
Limitations to Keep in Mind
A 42% LDL reduction is meaningful, but it may not be enough for everyone. People with very high baseline LDL, established heart disease, or diabetes often need at least a 50% reduction. In those cases, the standard 10 mg or 20 mg doses are more appropriate. Moving from 2.5 mg to 5 mg costs you only about 4.5% more LDL lowering, but stepping up to 10 mg or 20 mg brings progressively larger total reductions.
Splitting tablets also introduces some variability. A 5 mg pill cut in half won’t always produce two perfectly equal 2.5 mg pieces, especially if the tablet isn’t scored. This isn’t dangerous, but it means your actual dose may fluctuate slightly from day to day.
The other consideration is that cardiovascular outcome trials, the large studies showing that statins prevent heart attacks and strokes, were conducted at standard doses (typically 5 mg and above for rosuvastatin). The 2.5 mg dose has strong evidence for lowering LDL, but the direct evidence linking it to fewer cardiovascular events is less robust simply because it wasn’t the dose tested in those major trials. That said, the connection between lower LDL and fewer heart events is well established across decades of research, so a meaningful LDL drop at any dose carries real benefit.